Full text
PDF

Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GALTON D. A. Myleran in chronic myeloid leukaemia; results of treatment. Lancet. 1953 Jan 31;264(6753):208–213. doi: 10.1016/s0140-6736(53)90885-x. [DOI] [PubMed] [Google Scholar]
- HAUT A., ABBOTT W. S., WINTROBE M. M., CARTWRIGHT G. E. Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy. Blood. 1961 Jan;17:1–19. [PubMed] [Google Scholar]
- KYLE R. A., SCHWARTZ R. S., OLINER H. L., DAMESHEK W. A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy. Blood. 1961 Nov;18:497–510. [PubMed] [Google Scholar]
- LEAKE E., SMITH W. G. DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY. Lancet. 1963 Aug 31;2(7305):432–434. doi: 10.1016/s0140-6736(63)92173-1. [DOI] [PubMed] [Google Scholar]
- MARINHO H. M., MARTINS P. C. 1-4 Dimetanosulfoniloxibutano (G.T. 41- myleran) na terapêutica da leucemia mielóide crônica. Arq Bras Med. 1956 May-Jun;46(5-6):161–172. [PubMed] [Google Scholar]
- OLINER H., SCHWARTZ R., RUBIO F., DAMESHEK W. Interstitial pulmonary fibrosis following busulfan therapy. Am J Med. 1961 Jul;31:134–139. doi: 10.1016/0002-9343(61)90229-7. [DOI] [PubMed] [Google Scholar]